Immunotherapy through the Lens of Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The landscape of non-small cell lung cancer has changed dramatically over the past decade. This is largely due to the introduction of immunotherapy, and in particular, immune checkpoint blockade inhibitors. Anti-PD-1 immunotherapy is now standard treatment for patients with non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanley, Robyn, Flanagan, Saoirse, Reilly, David O’, Kearney, Ella, Naidoo, Jarushka, Dowling, Catríona M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252117/
https://www.ncbi.nlm.nih.gov/pubmed/37296957
http://dx.doi.org/10.3390/cancers15112996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252117/
https://www.ncbi.nlm.nih.gov/pubmed/37296957
http://dx.doi.org/10.3390/cancers15112996

Ejemplares similares